Equity and representation in oncology clinical evidence for FDA-approved treatments and the impact of COVID-19 - Poll - MDSpire

Equity and representation in oncology clinical evidence for FDA-approved treatments and the impact of COVID-19

  • By

  • Hao Cheng

  • Jun Li

  • Ningying Mao

  • May 1, 2026

  • 0 min

Share

Original Source(s)

Equity and representation in oncology clinical evidence for FDA-approved treatments and the impact of COVID-19

  • by Hao Cheng, Jun Li, Ningying Mao

  • May 1, 2026

Related Content

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity